On Tuesday, Symantec Corporation (NASDAQ:SYMC)’s shares inclined 0.90% to $23.66.
Symantec Corporation (SYMC) rolled out an improved version of the cloud-based security service product – Data Loss Prevention (DLP) 14. This product promises total security with regard to information storage, ruling out the possibilities of data loss or breach.
The new DLP 14 integrates Microsoft’s MSFT Office 365 and Azure, targeting organizations that utilize it for cloud-based email storage. Simultaneously, Symantec reached a planned partnership with Box, a cloud storage provider. The partnership aims to develop a product combining DLP 14 with the Box platform to provide greater visibility and control over a company’s data. Meanwhile, we strongly believe that this innovative product and solution will assist Symantec win customers, thereby increasing business volume.
The growing security threats and hacking attacks over the past year or so have revealed the increasing sophistication of the hackers and innovative hacking techniques. In order to cater to the growing demand for security solutions, the company has launched the DPL 14 service, which will considerably strengthen its attack prevention solutions. DLP 14 assists customers to assess the level of vulnerability, detect threats and mitigate intellectual property theft. Through this launch, Symantec will significantly expand its information protection portfolio, thereby meeting the growing business needs.
Synthetic Biologics Inc (NYSEMKT:SYN)’s shares dropped -14.39% to $2.38.
Synthetic Biologics Inc (SYN) a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, dosed the first participant in a second Phase 2a clinical trial of SYN-004. This trial will evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, in the presence of the proton pump inhibitor (PPI), esomeprazole. SYN-004 is the Company’s candidate therapy designed to degrade certain intravenous (IV) beta-lactam antibiotics within the GI tract and maintain the natural balance of the gut microbiome for the prevention of C. difficile infection, antibiotic-associated diarrhea (AAD) and secondary antibiotic-resistant infections.
PPIs are often used prophylactic ally in hospitalized patients. Therefore, with guidance from the U.S. Food and Drug Administration (FDA), Synthetic Biologics is conducting this study to demonstrate the ability of SYN-004 to degrade an intravenous (IV) antibiotic in the presence of a PPI.
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV) antibiotics for the prevention of C. difficile infection; an oral statin treatment to reduce the impact of methane producing organisms on irritable bowel syndrome with constipation (IBS-C); and a monoclonal antibody combination for the treatment of Pertussis.
At the end of Tuesday’s trade, FedEx Corporation (NYSE:FDX)‘s shares dipped -0.09% to $182.25.
FedEx Corporation (FDX) said it has adopted mark-to-market pension accounting for its defined benefit pension and other postretirement plans. This accounting change will have no effect on employees’ pension benefits or the funding requirements for any FedEx pension plans or FedEx cash flows.
This accounting method will make FedEx’s operating performance easier to understand and more transparent by right away recognizing actuarial gains and losses in the fourth quarter of the fiscal year rather than amortizing them over many years. Mark-to-market accounting has been adopted by many large U.S. corporations, and is considered the preferred accounting method because it provides a more current picture of pension plan performance.
FedEx also declared it will lower its predictable return on plan assets to 6.50 percent for segment reporting in all periods and on a merged basis starting in fiscal 2016. This change reflects its outlook for long-term investment returns and the current strategy for its investment portfolio.
FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. The company’s FedEx Express segment provides various shipping services for the delivery of packages and freight; international trade services specializing in customs brokerage, and ocean and air freight forwarding services; international trade advisory services, such as assistance with the customs-trade partnership against terrorism program; and customs clearance services, in addition to global trade data, an information tool that allows customers to track and manage imports.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
